Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 785-790

  Bladou, Franck ^a,b   Vessella, Robert L ^a   Buhler, Kent R ^a   Ellis, William J ^a   True, Lawrence D ^a   Lange, Paul H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD LEVEL; CASTRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CELL DIVISION; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON; MIDDLE AGED; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029956738     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N     Document Type: Article

References (27)

1. BARR, P.J. and TOMEI, L.D., Apoptosis and its role in human disease. Bio/Technology, 12, 487-493 (1994).
2. BERGES, R.R., FURUYA, Y., REMINGTON, L., ENGLISH, H.F., JACKS, T. and ISAACS, J.T., Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. nat. Acad. Sci. (Wash.), 90, 8910-8914 (1993).
3. BRANDSTROM, A., WESTIN, P., BERGH, A., CAJANDER, S. and DAMBER, J.E., Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Cancer Res., 54, 3594-3601 (1994).
4. COLLINS, R.J., HARMON, B.V., GOBE, G.C. and KERR, J.F.R., Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61, 451-453 (1992).
5. COLOMBEL, M., OLSSON, C.A., NG, P.Y., and BUTTYAN, R., Hormone-regulated apoptosis results from re-entry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52, 4313-4319 (1992).
6. COLOMBEL, M., SYMMANS, F., GIL, S., O'TOOLE, K.M., CHOPIN, D., BENSON, M., OLSSON, C.A., KORSMEYER, S. and BUTTYAN, R., Detection of the apoptosis-suppressing oncoprotein hcl-2 in hormone-refractory human prostate cancers. Amer. J. Pathol., 143, 390-400 (1993).
7. COTTER, T.G., LENNON, S.V., GLYNN, J.G. and MARTIN, S.J., Cell death via apoptosis and its relationship to growth. Development and differentiation of both tumour and normal cells. Anticancer Res., 10, 1153-1160 (1990).
8. DAVIES, P. and EATON, C.L., Regulation of prostate growth. J. Endocrinol., 131, 5-17 (1991).
9. ENGLISH, H.F., KYPRIANOU, N. and ISAACS, J.T., Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate, 15, 233-250 (1989).
10. CLEAVE, E.M., HSIEH, J.T., WU, H.C., VON ESCHENBACH, A.C. and CHUNG, L.W.K., Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res., 52, 1598-1605 (1992).
11. GREEN, D.R., BISSONNETTE, R.P. and COTTER, T.G., Apoptosis and Cancer. Important advances in oncology, pp. 37-52, J.B. Lippmcott Co., Philadelphia (1994).
12. ISAACS, J.T. and COFFEY, D.S., Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res., 41, 5070-5075 (1981).
13. ISAACS, J.T., Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr. Opin. Oncol., 6, 82-89 (1994).
14. JANEK, P., BRIAND, P. and HARTMAN, N.R., The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone dependent GR mouse mammary tumors. Cancer Res., 35, 3698-3704 (1975).
15. 2+-dependent endonudease as an early event in castration-induced prostatic cell death. Prostate, 13, 103-117 (1988).
16. KYPRIANOU, N., ENGLISH, H.F. and ISAACS, J.T., Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753 (1990).
17. KYPRIANOU, N. and ISAACS, J.T., Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122, 552-562 (1988).
18. LANDSTRÖM, M., DAMBER, J.E. and BERGH, A., Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate. Cancer Res., 54, 4281-4284 (1994).
19. LEO, M.E., BILHARTZ, D.L., BERGSTRALH, E.J. and OESTERLING, J.E., Prostate specific antigen in hormonally treated stage D2 prostate cancer: Is it always an accurate indicator of disease status? J. Urol., 145, 802-806 (1991).
20. LIU, A.Y., COREY, E., BLADOU, F., LANGE, P.H. and VESSELLA, R.L., Prostatic cell lineage markers: emergence of bcl2+ cells of human prostate cancer xenograft LuCaP 23 following castration. Int. J. Cancer, 65, 85-89 (1996).
21. MCDONNELL, T.J., TRONCOSO, P., BRISBAY, S.M., LOGOTHETIS, C., CHUNG, L.W.K., HSIESH, J.T., TU, S.M. and CAMPBELL, M.L., Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
22. MURPHY, G.P., Is chemotherapy effective in the treatment of prostatic cancer? Clin. Oncol., 2, 641-646 (1988).
23. MURPHY, W.M., SOLOWAY, M.S. and BARROWS, G.H., Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer, 68, 821-828 (1991).
24. WARE, J.L., Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metast. Rev., 12, 287-301 (1993).
25. WESTIN, P., BERGH, A. and DAMBER, J.E., Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate but not in the highly differentiated Dunning R-3327PAP prostatic adenocarcinoma. Prostate, 22, 65-74 (1993).
26. WESTIN, P., STATTIN, P., DAMBER, J.E. and BERGH, A., Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Amer. J. Pathol., 46, 1368-1375 (1995).
27. WYLLIE, A.H., Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metast. Rev., 11, 95-103 (1992).